Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study ; volume:24 ; number:1 ; day:28 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
BMC pulmonary medicine ; 24, Heft 1 (28.10.2024), 1-10, 12.2024

Creator
Milesi, Jules
Sampol, Emmanuelle
Benyamine, Audrey
Diai, Shani
Coiffard, Benjamin
Nieves, Ana
Granel, Brigitte
Reynaud-Gaubert, Martine
Bermudez, Julien
Contributor
SpringerLink (Online service)

DOI
10.1186/s12890-024-03361-7
URN
urn:nbn:de:101:1-2501172138362.624787025857
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:19 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Milesi, Jules
  • Sampol, Emmanuelle
  • Benyamine, Audrey
  • Diai, Shani
  • Coiffard, Benjamin
  • Nieves, Ana
  • Granel, Brigitte
  • Reynaud-Gaubert, Martine
  • Bermudez, Julien
  • SpringerLink (Online service)

Other Objects (12)

Usefulness of nailfold videocapillaroscopy for systemic sclerosis

Usefulness of nailfold videocapillaroscopy for systemic sclerosis

Pathogenesis of interstitial lung disease in systemic sclerosis

Pathogenesis of interstitial lung disease in systemic sclerosis

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)

Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?

Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?

Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

Expert consensus on the management of systemic sclerosis-associated interstitial lung disease

Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease

Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease

Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases

Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases

CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease

CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease

Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!

Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis

Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis

Related objects